Mr. Ahumada has been with Hôpital Charles Lemoyne since 2021. He obtained his bachelor's degree in physics from the Université de Montréal, as well as a CAMPEP master's degree in medical physics at the same institution.

Joanne Alfieri is an associate professor in the Department of Oncology, McGill University since February 2012. She is a radiation oncologist who specializes in the treatment of gynaecological and gastrointestinal malignancies at the McGill University Health Centre. Dr. Alfieri earned her medical degree and her post-graduate radiation oncology training at McGill. She completed a Post-graduate Fellowship in Gynaecology Oncology and MRI-guided Brachytherapy at the Peter MacCallum Cancer Centre in Melbourne, Australia.  Dr. Alfieri is the lead for the gynecological site group as well as the brachytherapy lead for the MUHC. She initiated the MRI-guided brachytherapy program at McGill, and her current research interests lie in the evaluation of this program with the aim of improving the long-term outcomes and minimizing treatment-related toxicity in gynaecological cancer patients as well as in investigating alternate treatment options for locally advanced cervix cancer.  She has a keen interest in medical education and is the post-graduate residency training Program Director for radiation oncology since February 2015 as well as Associate Chair (Education) for the Gerald Bronfman Department of Oncology of McGill University where oversees undergraduate, graduate, and post-graduate training programs in medical, surgical and radiation oncology. Merci!      

Dr. Bahoric completed his medical school in Rijeka, Croatia. He completed his Royal College Fellowship Program in Radiation oncology in Toronto. He works as staff radiation oncologist at the Jewish General Hospital in Montreal. He is assistant professor at McGill University. Apart from teaching he is involved in various administrative activities. His areas of interest and expertise are the gynecological, genitourinary and hematological malignancies. Particularly, he is interested in brachytherapy. He offers both intracavitary and interstitial for gynecological malignancies. He performs adjuvant accelerated partial breast irradiation via interstitial brachytherapy. Dr. Bahoric participates in nationwide studies in prostate cancer. As part of the studies he offers and performs HDR prostate brachytherapy. He is past president of Canadian Brachytherapy Group and is still active participant in this group.

Dr. Beaulieu is a full professor, Director of the CAMPEP graduate program and also Director of the Cancer Research Centre at Université Laval. He served on the Board of the Canadian Organization of Medical Physicists as President Elect, President and Past President (2010-2016). He is a member of the AAPM Brachytherapy Subcommittee as well as two associated Working Groups (Robotics and Clinical Applications), is the Chair of TG317 on tracking technology for brachytherapy, a member of the ESTRO In Vivo dosimetry working group, was the Chair of TG-186 and until recently led the AAPM/ESTRO/ABG Working Group on Model-Based Dose Calculations in Brachytherapy. He has mentored over 150 highly qualified personals, published 220 peer-reviewed manuscripts and 465 refereed abstracts at national and international meetings. He is a recognized expert on topics related to scintillation dosimetry and brachytherapy. Luc

Dr. Memory Bvochora-Nsingo is a highly dedicated and self-motivated clinical oncologist with over 20 years of experience in managing cancers. Her passion is in the prevention and treatment of cervical cancer. With a deep commitment to patient care, she has played a pivotal role in advancing cervical cancer treatment in Botswana by pioneering brachytherapy and improving access to innovative care in under-resourced settings. Her expertise and passion for oncology have earned her recognition on international platforms where she has presented groundbreaking research at leading conferences.

Dr. Albert J. Chang, MD, PhD is the Vice Chair of Surgical Services and Director of Brachytherapy at the University of California, Los Angeles.  He is a radiation oncologist that specializes in brachytherapy to all sites of the body.  He is actively involved in the American Brachytherapy Society and is the Chair of the Advisory Council.  His research interests are in optimizing brachytherapy with the use of systemic treatments.   

Yannick Chassé graduated from Ahuntsic College in 2013 and his a member of the brachytherapy team at the Hôpital Charles Lemoyne since 2020.

Zhe (Jay) Chen, PhD, is a Professor and Vice Chair for Physics Research & Education in the Department of Therapeutic Radiology at Yale University School of Medicine. He is ABR board-certified in therapeutic medical physics and serves as the Smilow Chief Physicist at Yale New Haven Hospital. Dr. Chen, a Fellow of the American Association of Physicists in Medicine, chaired the AAPM Task Group 267, which recently published A Joint AAPM GEC-ESTRO Report on Biophysical Models and Tools for the Planning and Evaluation of Brachytherapy. In addition to his clinical practice, he has served as a Principal Investigator on an NIH R01 grant investigating the effects of prostate edema in permanent interstitial brachytherapy and as a Co-Investigator on six other U.S. federal research grants. Dr. Chen has published over 110 peer-reviewed research articles and presented more than 200 abstracts at national and international meetings. His current research interests focus on basic radiation dosimetry and the radiobiological elucidation of treatment strategies in radiation therapy.damentale des rayonnements et l'élucidation radiobiologique des stratégies de traitement en radiothérapie.  

“Dr. Chino is an Associate Professor with Tenure of Radiation Oncology and the Director of Brachytherapy at the Duke Cancer Center. He graduated from the Indiana University School of Medicine in 2004, completing residency at Duke University Medical Center in 2009.  He has authored over 130 publications in the peer reviewed literature, and his research interests are concentrated in radiation therapy and brachytherapy for gynecologic and ocular cancers, radiation in low/middle income countries, as well as health services and disparities.  He was lead author of the ASTRO guidelines task force for cervical cancer, and served as the GYN section editor at the International Journal of Radiation Oncology Biology and Physics. He has been designated a Fellow of ASTRO and the ABS, and currently serves on the ABS board of directors."

Dr Crook did her medical training at the University of Toronto, Residency in Radiation Oncology at the Princess Margaret Hospital and is currently a Full Professor of Radiation Oncology at the University of British Columbia. She is a staff Radiation Oncologist in Kelowna BC where she has developed image-guided HDR gynecologic brachytherapy, US-planned HDR prostate brachytherapy, HDR interstitial and surface mold penile brachytherapy and permanent seed brachytherapy for breast cancer. She is former president of the Board of the American Brachytherapy Society, recipient of the Thom Shanahan Distinguished Brachytherapy Educator Award and the ABS 2017 Henschke Award. She is also the first to hold a Brachytherapy Research Chair position in British Columbia.

Dr Derashodian is a radiation oncologist working at BC Cancer Kelowna.. She graduated from Université de Montreal’s medical school in 2005. She then completed her residency in radiation oncology at Université Laval. She pursued her academic training at University of Miami with a fellowship in Urologic cancers under the supervision of Dr Alan Pollack. She then started her practice at Centre Intégré de Cancérologie de la Montérégie, at Charles LeMoyne hospital, and gained expertise in general brachytherapy.  Her main areas of expertise include urologic, gynecologic, and skin cancer, as well as general brachytherapy.

Phillip M. Devlin, MD, FACR, FASTRO, FFRRCSI(Hon) is Associate Professor of Radiation Oncology at Harvard Medical School and Chief of the Division of Brachytherapy in the Department of Radiation Oncology at the Dana-Farber/Brigham and Women’s Cancer Center. Dr. Devlin earned his medical degree at the University of Virginia School of Medicine in 1991 and completed his residency in Radiation Oncology at the University of Pennsylvania in 1995, followed by a specialized fellowship in brachytherapy at Memorial Sloan-Kettering Cancer Center in 1996.   In addition to lecturing extensively both nationally and internationally, Dr. Devlin has more than 100 published manuscripts and book chapters, and is editor of the text, Brachytherapy: Applications and Techniques, now in its second edition. He is a past President of the Massachusetts Radiological Society and was previously a member of the Board of Directors of the American Society for Radiation Oncology (ASTRO). In 2008, he was named a Fellow of the American College of Radiology (FACR), and in 2013 he became both a Fellow of ASTRO (FASTRO) and a Faculty of Radiology Honorary Fellow in the Royal College of Surgeons of Ireland (FFRRCSI[Hon]) and a Fellow of the American Brachytherapy Society. Dr. Devlin led two funded studies as part of the ACR’s Quality Research in Radiation Oncology (QRRO) project. His current research focus is on radioreponsiveness and gene expression in cutaneous lymphoma treated with brachytherapy. He continues to lead internationally in developing and deploying innovative brachytherapy techniques to expand the scope of practice, teaching and research.  

Bio: Simon Du Perron specializes in privacy law and technology law. He povides strategic advice to businesses and public bodies on variety of issues, including compliance with Quebec Law 25, implementing privacy programs, conducting Privacy Impact Assessments (PIAs) and deploying AI solutions responsibily. Simon holds a LL.B and LL.M (information Technology Law) from the Université de Montréal and he is a certified Artificial Intelligence Governance Professional (AIGP) anf information Privacy Professional/Canada (CIPP/C) from the International Association of Privacy Professionnal (IAPP). Simon is frequently invited to speak at cnferences and has written several publications on the interaction between law and new technologies. He is the author of the book Droit à la vie privée, mégadonnées et intelligence artificielle- Cadre Juridique en matière de protection des renseignements personnels published by LexisNexis Canada in 2022.  

Shirin A. Enger is a tenured associate professor at Gerald Bronfman Department of Oncology, McGill University, and Canada research chair in medical physics. Her main research interest is brachytherapy with an overall aim to enable patient-specific brachytherapy dose planning and delivery. She leads a research group with focus on novel brachytherapy technology. Dr. Enger completed her PhD at Uppsala University, Sweden in 2008, and her postdoctoral fellowship at Université Laval, Quebec, Canada during 2009 to 2011. During 2012 to 2014 she held a position as assistant professor in Medical Physics at Uppsala University prior moving to Montreal and her current position at McGill University.

Dr. Emily Yumeko Hirata is the Chief of Clinical Physics and Associate Professor at the University of California, San Francisco, and oversees the clinical operations and QA program for all of UCSF. She is also a Physicist surveyor and serves on the Radiation Oncology Practice Accreditation (ROPA) Committee for the American College of Radiology. In addition, she volunteers with the American Board of Radiology, and is an active curriculum advisor and lecturer with Rayos Contra Cancer. Within AAPM, Dr. Hirata serves on numerous committees including Vice Chair of the MPLA Community Subcommittee, the IHE-RO Planning Committee, and on the TG263U1 subcommittee. She is active in medical physics education, mentorship, and improving efficiency, safety, and effectiveness of clinical physics practices.

Dr. I-Chow "Joe" Hsu is an internationally recognized radiation oncologist with special expertises in brachytherapy and hyperthermia. Dr. Hsu’s research investigates the application of Hight Dose Rate (HDR) brachytherapy, a highly precise and conformal treatment that delivers radiotherapy by temporarily placing a minute radioactive source in the tumor using minimal invasive, image guided procedures.  His research in hyperthermia, a moderate temperature elevation (40-45° C) of the targeted tumor, explores the synergy between thermal therapy and radiotherapy to improve treatment efficacy without increasing treatment related toxicity.  His research in the treatment of genitourinary and gynecologic malignancies have lead to improved clinical outcomes and effective novel treatments for challenging clinical conditions. Dr. Hsu earned a medical degree at the Johns Hopkins School of Medicine. He is an active member of American Society for Radiation Oncology, American Brachytherapy Society and Society for Thermal Medicine.  He has been recognized as a Fellow of American College of Radiology and as a Fellow of American Society for Radiation Oncology.

Dr. Fleur Huang is a radiation oncologist at the Cross Cancer Institute in Edmonton, and Associate Professor in the Department of Oncology at the University of Alberta, where she is a member of the Women and Children’s Health Research Institute. She maintains a busy clinical practice, focused on women's cancers and palliative radiotherapy. Dr. Huang holds a medical degree from McGill University, where she also completed residency in Radiation Oncology. This was followed by Breast and Gynecologic subspecialty training at the Princess Margaret Hospital. With growing clinical experience came deepening professional interests in Global Health and Health Systems, and she earned an MPH at the Johns Hopkins Bloomberg School of Public Health. Dr. Huang is a core member of CancerCare Alberta’s Brachytherapy Centre of Excellence working group, advancing and advocating for brachytherapy care and research from the trenches. Recent multidisciplinary forays have explored house-made MRI-based uterine deformation and normal tissue autocontouring deep learning tools, and first-in-kind prototyping of a virtual reality simulator for cervical brachytherapy intracavitary/interstitial applicator insertion. She has been participating in the EMBRACE Collaborative Group (www.embracestudy.dk) since her first study enrolment in 2011, and still leads the team that was among the top-10 accruers to EMBRACE-I and EMBRACE-II.

Dr. Justin Jagodinsky attended the University of Wisconsin–Madison, where he earned both an MD and a PhD. He completed his graduate work in the laboratory of Dr. Zachary Morris, studying the effects of radiation on the tumor immune microenvironment. In his preclinical work, he elucidated how various forms of radiation—including external beam radiation and radiopharmaceuticals—impact immune activation both locally within the tumor and systemically. Additionally, his research has explored the combination of brachytherapy and immunotherapy to enhance anti-tumor immune responses, particularly in metastatic cancer. He has received recognition for his research, including an NIH F30 award supporting his studies on how radiation and immunotherapy can be combined to improve outcomes for patients with “cold” tumors that are less responsive to immune checkpoint inhibitors. Dr. Jagodinsky has published several peer-reviewed articles in high-impact journals, including Science Translational Medicine and Nature Communications, holds two patents related to his graduate work, and has presented at national oncology conferences. He serves as a review editor for Frontiers in Oncology and as an ad hoc reviewer for several other radiation 

Dr. Xun Jia is Professor and Chief of the Medical Physics Division within the Department of Radiation Oncology and Molecular Radiation Sciences at the Johns Hopkins University School of Medicine. He earned his Ph.D. in physics from the University of California Los Angeles in 2009 and received postdoctoral training in medical physics at the Department of Radiation Oncology and Applied Sciences, University of California San Diego, from 2009 to 2011. Throughout his career, Dr. Jia has been actively involved in impactful research, contributing to areas such as medical image reconstruction, GPU-based Monte Carlo radiation transport simulation, deep learning applications for image processing and radiotherapy treatment planning, and the advancement of technologies for preclinical small animal radiation research. His has published over 190 peer-reviewed manuscripts, and his research endeavors have received support from federal, state, industrial, and charitable funding agencies. Dr. Jia currently serves as Executive Editorial board member for the Physics in Medicine and Biology journal, as well as the position of Associate Editor for the Medical Physics journal, IEEE Transactions on Medical Imaging, and several other journals. Recognizing his significant contributions to the field, he was honored with the 2017 John Laughlin Young Scientist Award.

With an MD degree from the Université de Montréal, Dr. Marjory Jolicoeur founded Curietherapies in 2012, a non-profit organization that she still presides over today. A renowned radiation oncologist, she did her residency at Université de Montreal in 1996, before completing a brachytherapy fellowship at the Centre Georges-François Leclerc located in Dijon (France). In 1997, she started working at the department of Radiation Oncology of Université de Montréal, where she still teaches. A mere two years later, she was appointed medical consultant for all planning, construction and equipment selection processes of the new Radiation Oncology department of Hospital Charles-Le Moyne. She innovates by equipping the department with a suite and a comprehensive image-guided brachytherapy program. As a brachytherapy specialist, she has special research interests in its application to pathologies such as breast, genitourinary and gynecologic cancers. Her main focus is on the development of image guided implant procedures, the use of MRI in brachytherapy and the precision delivery of conformal high dose rate brachytherapy. She also teaches brachytherapy nationally and internationally. 

Andrée Jutras graduated from Ahuntsic College in 1994.  She has been a member of the brachytherapy team at the Centre Hospitalier de l'Université de Montréal since 2005 and has been Chief Brachytherapy Technologist since 2017.

Dr. Marisa Kollmeier is an Associate Physician in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center in New York where she joined the faculty in 2004 following her residency training at Mount Sinai Medical Center. Since 2007, she has been an active member of the Brachytherapy Service at MSKCC and performs prostate LDR and HDR brachytherapy, intracavitary and interstitial GYN brachytherapy, as well as HDR mold and HDR intraoperative radiation therapy.  She is actively involved in the training of many residents and fellows in brachytherapy-based therapies. Dr. Kollmeier is the chair of the Radiation Oncology Quality Assurance Committee and participates actively in both institutional QA activities as well serving on the Multidisciplinary QA Committee for ASTRO. She has been an active member of ABS since 2004. She has many publications in journals including Brachytherapy, the International Journal of Radiotherapy and Oncology Biology Physics, Practical Radiation Oncology and Radiotherapy and Oncology on prostate cancer, brachytherapy as well as other topics.  

Dr Lagmago completed his PhD in Atomic and Molecular Physics at Institut de Mathématiques de Sciences Physiques (Bénin) and Université Catholique de Louvain (Belgium). He was postdoctoral research associate for 3 years at the University of Nebrasla-Lincon (USA) and a reseach associate for 3 years at the University of Sherbrooke (Canada). He later completed a Masters in Medical Physics at McGill University and a residency in Medical Physics at the Ottawa Hospital (Ontario, Canada). He is a member of the Canadian College of Physicists in Medicine and has been working as a clinical medical Physicist at Hospital Charles-Lemoyne since 2010. His area of interest and expertise are in brachytherapy, accelerator quality assurance and dosimetry.

Renée has been working as a medical physicist at CHUM since 2006.  Her primary interests are in applying risk management strategies to radiation oncology, low dose rate (LDR) and high dose rate (HDR) prostate brachytherapy and teaching physics to radiation oncology residents.  Renée has been on the prostate brachytherapy team at CHUM over ten years.  She was responsible for commissioning the UroNav system with electromagnetic catheter reconstruction for clinical use for HDR prostate brachytherapy.  Renée is also Chargée d’enseignement clinique with the Université de Montréal and has been responsible for the physics training component of the radiation oncology residency program.  In 2019, a full review of the physics curriculum and new structure to the physics courses to implement Competence by Design was implemented.  Renée also volunteered with the Canadian College of Physicists in Medicine (CCPM) many years, culminating with the role of CCPM Chief Examiner from 2015 to 2018. 

...

Eric Leung is a radiation oncologist and GYN Radiation Site Lead at Sunnybrook Odette Cancer Centre and Associate Professor at the University of Toronto, Department of Radiation Oncology. He is the Co-Chair of the Canadian Clinical Trials Group (CCTG) cervix working group, a member of the NRG Oncology Cervix Core Committee and sits on the NCI Cervical Cancer Task Force. He is the University of Toronto Department of Radiation Oncology Fellowship Director for the Brachytherapy AFC Program and is an Associate Editor for Brachytherapy and the Red Journal.

Fellowship en curiethérapie; Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA MSc médecine expérimentale; Faculté de médecine, University Laval, Québec, Québec “Diplôme d’étude supérieurs en radio-oncologie”; University Laval, Québec, Québec Doctorat en médecine; Faculté de médecine, Université Laval, Québec, Québec Bachelier en Pharmacie; École de pharmacie, Université Laval, Québec, Québec

Dr. Gerard Morton is a radiation oncologist at the Sunnybrook Odette Cancer Centre and an associate professor at the University of Toronto.  He has a clinical and academic focus in prostate cancer and brachytherapy, is program director of the University of Toronto Brachytherapy AFC training program, and is chair of the Royal College Brachytherapy AFC committee.  He co-chairs several ongoing multicentre clinical trials, is co-chair of the ASTRO Annual Meeting GU Track, and is North American Editor for Clinical Oncology.  He has published extensively on prostate cancer.   ...

Internship at Centre Hospitalier Universitaire Avéroes Casablanca 2007-2009. Diploma in General Medicine Faculty of Medicine and Pharmacy Casablanca University Hassan II Ain chock in 2009. Diploma in advanced radiotherapy techniques Faculty of Medicine Murcia Spain 2011- 2012. Specialty Diploma in Radiotherapy Faculty of Medicine and Pharmacy Casablanca Université Hassan II Ain Chock in 2013. Assistant Professor Faculty of Medicine Mohammed VI University of Science and Health Casablanca March 2016. Diploma in Simulation in Health Sciences International Medical Center for Simulation IMSC 2017-2018. Diplôme en haute technicité Radiothérapie Faculté de Médecine Nice France 2018-2019. Diplôme Universitaire en Pédagogie médicale Faculté de Pharmacie UM6SS 2019-2020. Diploma in Epidemiology and Biostatistics 2020-2021. Associate Professor Faculty of Medicine Mohammed VI University of Science and Health Casablanca March January 2021. PhD in Immunology - Molecular Biology, option Genetics and Molecular Pathology September 2023. Member of the Institut de Recherche des Cancers. Member of the board of the Moroccan Cancer Society.

...

Alexandra Rink is a Lead Brachytherapy Physicist at the Princess Margaret Cancer Centre, a member of Ontario Health Gynecological Cancers Community of Practice, and an Assistant Professor in the Departments of Radiation Oncology and Medical Biophysics, at the University of Toronto. She completed her Ph.D. in the Department of Medical Biophysics under the co-supervision of Drs. Jaffray and Vitkin in 2008, focusing on in vivo methods for patient dosimetry.  After completing her Medical Physics residency at the University of Toronto, she joined the Medical Physics department at the Princess Margaret Cancer Centre in 2010. Alexandra’s passions are in vivo dosimetry and improvement in quality of care for brachytherapy patients through the application of Artificial Intelligence and Deep Learning methods. 

Marie-Pier St-Laurent graduated from Collège de Ste-Foy as a radiation oncology technologist and has been working at Hôpital Charles Lemoyne ever since. She then worked as a brachytherapy technologist from 2013 to 2023. She has held the position of brachytherapy coordinator and is currently assistant head of the brachytherapy sector. She is concerned about the situation of brachytherapy patients and is always looking for new ideas to serve them better. Member of the curietherapi.es committee since 2022

Alasdair Syme is a medical physicist at Nova Scotia Health, an Assistant Professor in the Department of Radiation Oncology at Dalhousie University and a Fellow of the Canadian College of Physicists in Medicine (CCPM). He is the Director of the CAMPEP-accredited graduate education program at Dalhousie and a former Chief Examiner of the CCPM. He completed his PhD in Medical Physics at the University of Alberta in 2004. His research interests include CT-based dosimetry for transarterial radioembolization (TARE), novel external beam radiotherapy treatment delivery techniques and radiation detector development.

Dr. James Tsui is an Assistant Professor and Radiation Oncologist at the McGill University Health Centre (MUHC). He holds a PhD in Computational Neuroscience, a Medical Degree (MD), and a professional Master’s in Artificial Intelligence. His research interests focus on the intersection of machine learning and medicine, with the goal of bringing artificial intelligence into his oncology research and clinical practice.

Vincent Turgeon is a medical physicist certified by the Canadian College of Physicists in Medicine since 2021. He completed his Master's degree in Medical Physics at McGill University, where he had the opportunity to work under the supervision of Professor Shirin Enger, a leading researcher in the field. After graduating, Vincent Turgeon completed his residency in medical physics at the Jewish General Hospital, where he acquired valuable expertise. He worked with dedication

Dr. Eric Vigneault received his medical degree from the University of Montreal in 1992. In addition to completing his residency training in radiation oncology at the CHUQ Hôtel-Dieu de Quebec Hospital in 1997, Dr. Vigneault obtained a Master of Science degree in experimental medicine in 1996. He also completed a one year and a half fellowship in brachytherapy and three-dimensional external beam radiation therapy at the University of California San Francisco under the supervision of Dr. Mack Roach in 1998. He is involved in brachytherapy at both the provincial and national levels, as Chair of the Province of Quebec brachytherapy committee, and was president of the Canadian Brachytherapy Group from 2002 to 2006. Dr Vigneault was head of the Hotel-Dieu of Quebec Radiation-Oncology Department from 2003 to 2007. Since September 2015 Dr Vigneault is the president of the Canadian Association of Radiation Oncology and the Titular of the new Research Chair on Image Guided Brachytherapy

"Ma’n H. Zawati (LL.B., LL.M., Ph.D. (DCL)) is an Associate Professor at McGill University's Faculty of Medicine and Health Sciences and the Research Director of the Centre of Genomics and Policy in the Department of Human Genetics. He is also an Associate Member in the Department of Medicine, the Department of Equity, Ethics and Policy and the Faculty of Law. His work is interdisciplinary, drawing together perspectives from law, ethics, genomics, and policy. His research mainly focuses on the legal, ethical and policy dimensions of health research and clinical care, specializing in data sharing, governance, professional liability, and the use of novel technologies (e.g., mhealth apps, WGS, WES and Artificial Intelligence). During COVID-19, Prof. Zawati was instrumental in establishing the ethics governance for multiple initiatives, including the Quebec COVID19 Biobank (BQC19), CGEn’s  HostSeq project and the COVID-19 Immunity Task Force. His work has facilitated access and use of data and samples across jurisdictions."